Yasmin A. Lyons

566 total citations
15 papers, 345 citations indexed

About

Yasmin A. Lyons is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yasmin A. Lyons has authored 15 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Yasmin A. Lyons's work include Ovarian cancer diagnosis and treatment (4 papers), Immune cells in cancer (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Yasmin A. Lyons is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Immune cells in cancer (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Yasmin A. Lyons collaborates with scholars based in United States, Israel and South Korea. Yasmin A. Lyons's co-authors include Anil K. Sood, Michael Frumovitz, Sherry Y. Wu, Keith Baggerly, Willem W. Overwijk, Robert L. Coleman, Pamela T. Soliman, Preetha Ramalingam, Lauren A. Byers and Jennifer K. Burzawa and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Yasmin A. Lyons

15 papers receiving 344 citations

Peers

Yasmin A. Lyons
Kentaro Noda Japan
Ignacio Ruz‐Caracuel Spain
M Fukayama Japan
Silvia D’Amico Italy
Iryna Samarska Netherlands
Jonathan Kessler United States
B Arbeille-Brassart France
Kentaro Noda Japan
Yasmin A. Lyons
Citations per year, relative to Yasmin A. Lyons Yasmin A. Lyons (= 1×) peers Kentaro Noda

Countries citing papers authored by Yasmin A. Lyons

Since Specialization
Citations

This map shows the geographic impact of Yasmin A. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasmin A. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasmin A. Lyons more than expected).

Fields of papers citing papers by Yasmin A. Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasmin A. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasmin A. Lyons. The network helps show where Yasmin A. Lyons may publish in the future.

Co-authorship network of co-authors of Yasmin A. Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Yasmin A. Lyons. A scholar is included among the top collaborators of Yasmin A. Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasmin A. Lyons. Yasmin A. Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mott, Sarah L., et al.. (2021). Multimodal perioperative pain protocol for gynecologic laparotomy is associated with reduced hospital length of stay. Journal of obstetrics and gynaecology research. 47(3). 1082–1089. 6 indexed citations
2.
Wagner, Michael J., Yasmin A. Lyons, Jean Siedel, et al.. (2021). Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Scientific Reports. 11(1). 9362–9362. 24 indexed citations
3.
Lyons, Yasmin A., Henry Reyes Pineda, Megan McDonald, et al.. (2020). Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy. International Journal of Gynecological Cancer. 30(6). 845–852. 34 indexed citations
4.
Lyons, Yasmin A., Megan McDonald, A.M. Newtson, et al.. (2019). Interval debulking surgery is not worth the wait: A National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy. Gynecologic Oncology. 154(1). e5–e6. 4 indexed citations
5.
Newtson, A.M., Johanna Mattson, Michael J. Goodheart, et al.. (2019). Prediction of optimal surgical outcomes with radiologic images using deep learning artificial intelligence. Gynecologic Oncology. 154. 156–156. 1 indexed citations
6.
Lyons, Yasmin A., et al.. (2019). Gynecologic Oncology: Challenges of Minimally Invasive Surgery In a Field of Maximal Complexities. Clinical Obstetrics & Gynecology. 63(1). 30–39. 4 indexed citations
7.
Haldar, Rita, Lee Shaashua, Hagar Lavon, et al.. (2018). Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome. Brain Behavior and Immunity. 73. 294–309. 62 indexed citations
8.
Mitamura, Takashi, Sunila Pradeep, Michael H. McGuire, et al.. (2017). Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene. 37(6). 722–731. 40 indexed citations
9.
Lyons, Yasmin A., Sherry Y. Wu, Willem W. Overwijk, Keith Baggerly, & Anil K. Sood. (2017). Immune cell profiling in cancer: molecular approaches to cell-specific identification. npj Precision Oncology. 1(1). 26–26. 66 indexed citations
10.
Bottsford-Miller, Justin, Monika Haemmerle, Michael J. Wagner, et al.. (2017). Aspirin-PC is a novel, safe and efficacious compound in ovarian cancer. Gynecologic Oncology. 145. 85–86. 1 indexed citations
11.
Lyons, Yasmin A., Sunila Pradeep, Jean M. Hansen, et al.. (2017). Abstract 788: Less is more: macrophage depletion via CSF1/CSF1R pathway improves anti-VEGF therapy after adaptive resistance. Cancer Research. 77(13_Supplement). 788–788. 1 indexed citations
12.
Dood, Robert, Archana S. Nagaraja, Yasmin A. Lyons, et al.. (2017). Knocking out stress: A systems-based identification of optimal drug combinations to improve ovarian cancer outcomes. Gynecologic Oncology. 145. 15–15. 1 indexed citations
13.
Frumovitz, Michael, Jennifer K. Burzawa, Lauren A. Byers, et al.. (2016). Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecologic Oncology. 141(3). 588–591. 57 indexed citations
14.
Lyons, Yasmin A., Aparna A. Kamat, Haijun Zhou, et al.. (2015). Non‐16/18 high‐risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL. Cancer Cytopathology. 123(7). 435–442. 11 indexed citations
15.
Lyons, Yasmin A., Michael Frumovitz, & Pamela T. Soliman. (2014). Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. Gynecologic Oncology Reports. 10. 28–29. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Noda Breakdown of academic impact, for papers by Ignacio Ruz‐Caracuel Breakdown of academic impact, for papers by M Fukayama Breakdown of academic impact, for papers by Silvia D’Amico Breakdown of academic impact, for papers by Iryna Samarska Breakdown of academic impact, for papers by Jonathan Kessler Breakdown of academic impact, for papers by B Arbeille-Brassart
Rankless by CCL
2026